Status:
COMPLETED
Incidence, Risk Factors and Endoscopic Retrieval of Proximally Migrated Pancreatic Stents
Lead Sponsor:
Changhai Hospital
Conditions:
Pancreatic Stenting
Pancreatic Stent Displacement
Eligibility:
All Genders
Brief Summary
This study intends to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.
Detailed Description
Endoscopic pancreatic stenting can be used to treat a variety of pancreatic disorders, including chronic pancreatitis-induced pancreatic duct stenosis, pancreatic schizophrenia, pancreatic leakage, pa...
Eligibility Criteria
Inclusion
- Pancreatic stent placement under ERCP;
- Pancreatic stent migration found by ERCP;
- Displaced pancreatic stent removal by ERCP technique.
Exclusion
- Incomplete ERCP records (e.g., missing stent size information);
- Immediate removal of pancreatic stent following implantation for a variety of reasons.
Key Trial Info
Start Date :
June 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
9073 Patients enrolled
Trial Details
Trial ID
NCT05431517
Start Date
June 30 2022
End Date
July 31 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, China, 200433